Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Zhonghua Xue Ye Xue Za Zhi ; 44(12): 1016-1021, 2023 Dec 14.
Artigo em Chinês | MEDLINE | ID: mdl-38503525

RESUMO

Objective: This study aimed to evaluate the efficacy and safety of daratumumab as a maintenance treatment after autologous hematopoietic stem cell transplantation (auto-HSCT) in patients with newly diagnosed multiple myeloma (NDMM) . Methods: The clinical data, hematological and renal response, and safety of 15 post-transplant patients with NDMM who had received daratumumab maintenance between May 1, 2022 and June 30, 2023 were retrospectively analyzed. Results: Fifteen patients (11 males and 4 females) with a median age of 58 (41-72) years were included. Thirteen patients did not receive daratumumab during induction therapy and auto-HSCT, 6 patients had renal impairment, and nine patients had high-risk cytogenetics. The median infusion of daratumumab was 12 (6-17) times, and the median duration of maintenance was 6 (1.5-12) months. The treatment efficacy was evaluated in all 15 patients, and daratumumab maintenance therapy increased the rate of stringent complete response from 40% to 60%. The renal response rate and median estimated glomerular filtration rate of six patients with RI-NDMM were also improved. During daratumumab maintenance therapy, the most common hematological grade 3 adverse event (AE) was lymphopenia [4 of 15 patients (26.67%) ], whereas the most common nonhematologic AEs were infusion-related reactions [7 of 15 patients (46.67%) ] and grade 3 pneumonia [5 of 15 patients (33.33%) ]. The five patients with pneumonia were daratumumab naive [5 of 13 patients (38.46%) ], with a median of 8 (6-10) infusions. Among them, the chest computed tomography of three patients showed interstitial infiltrates, and treatment with methylprednisolone was effective. With a median follow-up of 12 months, the 1-year overall survival rate was 93.33%, and only one patient died (which was not related to daratumumab treatment) . Conclusions: Daratumumab was safe and effective as a maintenance agent for post-auto-HSCT patients with NDMM, and AEs were controllable. The most common nonhematologic AE was grade 3 pneumonia, and a less dose-intense maintenance regimen for the first 8 weeks could reduce the incidence of pneumonia.


Assuntos
Anticorpos Monoclonais , Transplante de Células-Tronco Hematopoéticas , Mieloma Múltiplo , Pneumonia , Masculino , Feminino , Humanos , Pessoa de Meia-Idade , Idoso , Mieloma Múltiplo/tratamento farmacológico , Estudos Retrospectivos , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Transplante Autólogo , Pneumonia/etiologia , Dexametasona , Bortezomib/uso terapêutico
2.
Appl Opt ; 40(20): 3359-64, 2001 Jul 10.
Artigo em Inglês | MEDLINE | ID: mdl-18360360

RESUMO

We have improved the two-wave coupling amplification and the signal-to-noise ratio of an amplified signal with photorefractive cerium-doped potassium sodium strontium barium niobate (Ce:KNSBN) by employing optimum polarization orientation of the pump beam while the signal beam retains extraordinary polarization. The optimum polarization angle of the pump beam was found experimentally to be 30 degrees with respect to the extraordinary polarization direction in a symmetrically incident system. Nearly 1.9-times enhancement of the gain and nearly 3-times enhancement of the signal-to-noise ratio were achieved at a signal-to-pump beam intensity ratio of 1:40. At a beam intensity ratio of 1:2000, a two-wave coupling gain of nearly 500 was obtained, which is much higher than the gain previously reported. Modified coupled-wave equations that involve beam fanning with certain assumptions concerning the fanning parameters were used. The numerical solution is in good agreement with the experimental data. The results are compared with those obtained with a 45 degrees -cut BaTiO(3) crystal.

3.
Appl Opt ; 40(26): 4667-71, 2001 Sep 10.
Artigo em Inglês | MEDLINE | ID: mdl-18360507

RESUMO

Holographic recording with orthogonally polarized beams in a cesium-doped KNSBN [(K0.5Na0.5)0.2(Sr0.75Ba0.25)0.9Nb2O6] crystal has been studied. It was found that this kind of photorefractive crystal possesses high linear dichroism, which makes it suitable for use in polarization holography. The diffraction efficiency as a function of the polarization orientation of the reference beam and as a function of the fringe modulation at the optimum polarization orientation of the reference beam is experimentally investigated. Theoretical fitting based on Kahmann models was performed and agrees well with the experimental data. In the experiments, both polarization holography and conventional holography are used to record a binary object. The reconstruction shows that polarization holography with Ce:KNSBN is highly effective, exhibiting high diffraction efficiency and reduced fanning noise.

4.
Appl Opt ; 37(20): 4449-56, 1998 Jul 10.
Artigo em Inglês | MEDLINE | ID: mdl-18285896

RESUMO

The technique of moving gratings in a photorefractive crystal is applied to the edge enhancement of objects and edge-enhanced optical correlation. The nonlinear dependence of the optimum fringe velocity on the fringe modulation and the variation of the enhancement of the diffraction efficiency with fringe modulation at a fixed fringe velocity appropriate to high fringe modulations are experimentally investigated. It is shown that the diffraction at high fringe modulations, which corresponds to the high-spatial-frequency components of the Fourier spectrum, is enhanced by a factor of approximately 3.7, whereas the diffraction at low fringe modulations is suppressed by a factor of 0.6. The proposed technique has the advantages of real-time enhancement, arbitrary selection of the spatial frequency to be enhanced, and improved stability of the output. Experimental results of the edge enhancement of objects and edge-enhanced correlation are presented.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...